ACRO BIOMEDICAL CO., LTD. Retained Earnings
ACRO BIOMEDICAL CO., LTD. (ACBM) had Retained Earnings of -$32.82 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-14
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$32.82M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$32.80M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$32.76M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$32.80M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | -$32.82M 10-Q · filed 2026-08-14 |
| 2026-03-31 | -$32.80M 10-Q · filed 2026-05-05 |
| 2025-12-31 | -$32.76M 10-Q · filed 2026-08-14 |
| 2025-09-30 | -$32.80M 10-Q · filed 2025-11-10 |
| 2025-06-30 | -$32.68M 10-Q · filed 2025-08-05 |
| 2025-03-31 | -$32.67M 10-Q · filed 2025-07-24 |
| 2024-12-31 | -$32.66M 10-K · filed 2026-02-11 |
| 2024-09-30 | -$32.65M 10-Q · filed 2025-07-23 |
| 2024-06-30 | -$32.64M 10-Q · filed 2025-07-23 |
| 2024-03-31 | -$32.63M 10-Q · filed 2025-07-22 |
| 2023-12-31 | -$32.62M 10-K · filed 2025-07-24 |
| 2023-09-30 | -$32.60M 10-Q · filed 2025-07-11 |
| 2023-06-30 | -$31.01M 10-Q · filed 2023-08-14 |
| 2023-03-31 | -$27.81M 10-Q · filed 2023-08-02 |
| 2022-12-31 | -$23.81M 10-K · filed 2025-07-18 |
| 2022-09-30 | -$19.87M 10-Q · filed 2022-11-21 |
| 2022-06-30 | -$15.86M 10-Q · filed 2022-08-12 |
| 2022-03-31 | -$11.87M 10-Q · filed 2022-05-16 |
| 2021-12-31 | -$7.94M 10-K · filed 2023-07-21 |
| 2021-09-30 | -$4.08M 10-Q · filed 2021-11-22 |
| 2021-06-30 | -$1.09M 10-Q · filed 2021-08-23 |
| 2021-03-31 | -$298.15K 10-Q · filed 2021-05-24 |
| 2020-12-31 | -$238.65K 10-K · filed 2022-04-15 |
| 2020-12-30 | -$238.65K 10-Q · filed 2021-11-22 |
| 2020-09-30 | -$176.88K 10-Q · filed 2020-11-17 |
| 2020-06-30 | -$103.78K 10-Q · filed 2020-08-19 |
| 2020-03-31 | -$40.09K 10-Q · filed 2020-05-19 |
| 2019-12-31 | -$121.20K 10-K · filed 2021-04-02 |
| 2019-09-30 | -$45.33K 10-KT · filed 2020-03-27 |
| 2019-06-30 | $29.83K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $80.65K 10-Q · filed 2019-05-15 |
| 2018-12-31 | $250.40K 10-Q · filed 2019-02-14 |
| 2018-09-30 | $325.42K 10-KT · filed 2020-03-27 |
| 2018-06-30 | $171.75K 10-Q · filed 2018-08-14 |
| 2018-03-31 | $55.44K 10-Q · filed 2018-08-01 |
| 2017-12-31 | -$14.01K 10-Q · filed 2018-02-14 |
| 2017-09-30 | -$94.24K 10-K · filed 2018-12-28 |
| 2017-06-30 | -$133.74K 10-Q · filed 2017-08-11 |
| 2017-03-31 | -$121.85K 10-Q · filed 2017-05-22 |
| 2016-12-31 | -$99.41K 10-Q · filed 2017-02-14 |
| 2016-09-30 | -$91.99K 10-K/A · filed 2018-01-16 |
| 2016-06-30 | -$85.87K 10-Q · filed 2016-08-03 |
| 2016-03-31 | -$68.74K 10-Q · filed 2016-05-13 |
| 2015-09-30 | -$48.56K 10-K · filed 2016-12-16 |